GlassScriptPhysician profile
Ramyar Mahdavi
NPI 1346481645
$14,499.31
in general payments reported to CMS, 2019-2025
16 companies · $2,688 in 2025
The $2,688 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.43 · 2020: $482 · 2021: $427 · 2022: $3,598 · 2023: $2,577 · 2024: $4,679 · 2025: $2,688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $2,400 · Travel and Lodging: $2,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $2,399.51 |
| Travel and Lodging | $2,044.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,691.17 | 2022-2025 | Da Vinci Surgical System |
| Ethicon INC. | $2,244.57 | 2020-2023 | Monarch Platform |
| Olympus America INC. | $2,059.18 | 2022-2024 | Spiration Valve System, Spin Vision Video Processor |
| Noah Medical Corporation | $1,860.74 | 2023-2024 | Galaxy |
| Pulmonx Corporation | $433.42 | 2019-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Galvanize Therapeutics, INC | $397.98 | 2024-2025 | Aliya System |
| Glaxosmithkline, LLC. | $310.69 | 2024-2025 | Ojjaara, Trelegy Ellipta, Nucala |
| Medtronic, INC. | $200.82 | 2025 | Illumisite |
| Astellas Pharma US INC | $118.10 | 2025 | Xospata |
| Merck Sharp & Dohme LLC | $29.88 | 2025 | Winrevair |
| United Therapeutics Corporation | $27.86 | 2025 | Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.46 | 2025 | Ofev |
| Optinose US, INC. | $26.45 | 2024 | |
| Viatris Specialty LLC | $25.68 | 2025 | Yupelri |
| Ani Pharmaceuticals, INC. | $25.57 | 2025 | Purified Cortrophin Gel |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $20.74 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramyar Mahdavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.